PainFree Detailํ†ต์ฆ์„ ์ดํ•ดํ•˜๋Š” ๊นŠ์ด ์žˆ๋Š” ์ด์•ผ๊ธฐ
๊ด€์ ˆ์—ผ ๊ณตํ†ตยท์†๊ด€์ ˆ ยท DETAIL BLOG

์ˆœ์ž blog / Detail Blog ์›๋ฌธ ยท Google Drive ์›๋ณธ ํ™•์ธ โ†—

๐Ÿฉบ [์˜์‚ฌ์„ ์ƒ๋‹˜์˜ ๊ด€์ ˆ ์นผ๋Ÿผ] ์ถ”์šด ๋‚ ์”จ์™€ ๊น€์žฅ์ฒ , ์™œ ๋ฌด๋ฆŽ์ด ๋” ์‘ค์‹ค๊นŒ? (๋™๋‚จ์•„ ์—ฌํ–‰ ๊ฐ€๋ฉด ๋œ ์•„ํ”ˆ ์ง„์งœ ์˜ํ•™์  ์ด์œ  & 3๋Œ€ ๊ด€์ ˆ ๋ณดํ˜ธ๋ฒ•)

์•ˆ๋…•ํ•˜์„ธ์š”! ์ง„๋ฃŒ์‹ค์—์„œ ์ˆ˜๋งŽ์€ ๊ด€์ ˆ์—ผ ํ™˜์ž๋ถ„๋“ค์„ ๋งŒ๋‚˜๋ฉฐ ์–ด๋ฅด์‹ ๋“ค์˜ ๋‹ค๋ฆฌ์™€ ์†๋งˆ๋”” ๊ฑด๊ฐ•์„ ์ง€์ผœ๋“œ๋ฆฌ๋Š” ๋งˆ์ทจํ†ต์ฆ์˜ํ•™๊ณผ ์ „๋ฌธ์˜์ž…๋‹ˆ๋‹ค.

์˜์‚ฌ ์ƒํ™œ์„ ํ•˜๋ฉด์„œ ์ผ๋…„ ์ค‘ ๊ด€์ ˆ ํ™˜์ž๋ถ„๋“ค์ด ์œ ๋… ๋ชฐ๋ฆฌ๋Š” ์‹œ๊ธฐ๋ฅผ ๋ณด๋ฉด ๋”ฑ ๋‘ ๋ฒˆ์ด ์žˆ์Šต๋‹ˆ๋‹ค. ํ•˜๋‚˜๋Š” ๋น„๊ฐ€ ์ฃผ๋ฃฉ์ฃผ๋ฃฉ ๋‚ด๋ฆฌ๊ณ  ์Šตํ•œ ์žฅ๋งˆ์ฒ ์ด๊ณ , ๋˜ ํ•˜๋‚˜๋Š” ์ฐฌ ๋ฐ”๋žŒ์ด ๋ถˆ๊ธฐ ์‹œ์ž‘ํ•˜๋Š” ์Œ€์Œ€ํ•ด์ง€๋Š” ๊ณ„์ ˆ์ž…๋‹ˆ๋‹ค. ํŠนํžˆ ๋Šฆ๊ฐ€์„๋ถ€ํ„ฐ ๊ฒจ์šธ๋กœ ๋„˜์–ด๊ฐ€๋Š” ๊ธธ๋ชฉ์— ๊น€์žฅ์ฒ ๊นŒ์ง€ ๊ฒน์น˜๋ฉด, ์ง„๋ฃŒ์‹ค์„ ์ฐพ์œผ์‹œ๋Š” ํ™˜์ž๋ถ„๋“ค์˜ 90% ์ด์ƒ์ด ๊ทน์‹ฌํ•œ ๋ฌด๋ฆŽ๊ณผ ์†๋งˆ๋”” ํ†ต์ฆ์„ ํ˜ธ์†Œํ•˜์‹ญ๋‹ˆ๋‹ค.

์–ด๋ฅด์‹ ๋“ค๊ป˜์„œ๋Š” ๋Š˜ ์ €์—๊ฒŒ ์ด๋ ‡๊ฒŒ ๋ง์”€ํ•˜๊ณค ํ•˜์‹ญ๋‹ˆ๋‹ค.

"์„ ์ƒ๋‹˜, ์ œ๊ฐ€ ์ Š์—ˆ์„ ๋•Œ ๊ณ ์ƒ์„ ๋„ˆ๋ฌด ๋งŽ์ด ํ•ด์„œ, ๋ฌด๋ฆŽ์„ ํ˜น์‚ฌ์‹œํ‚ค๋Š” ๋ฐ”๋žŒ์— ์—ฐ๊ณจ์ด ๋‹ค ๋‹ณ์•„์„œ ์ด๋ ‡๊ฒŒ ๊ณจ๋ณ‘์ด ๋“  ๊ฑธ๊นŒ์š”?" "์ด์ƒํ•˜๊ฒŒ ๋‚ ์”จ๋งŒ ์ถ”์›Œ์ง€๋ฉด ๋ฌด๋ฆŽ์ด ์‘ค์‹œ๊ณ  ๋ปฃ๋ปฃํ•ด์ง€๋Š”๋ฐ, ์ž‘๋…„์— ๋™๋‚จ์•„์ฒ˜๋Ÿผ ๋”ฐ๋œปํ•œ ๋‚˜๋ผ๋กœ ์—ฌํ–‰์„ ๋‹ค๋…€์™”์„ ๋•Œ๋Š” ๊ฑฐ์ง“๋ง์ฒ˜๋Ÿผ ๋ฌด๋ฆŽ์ด ํ•˜๋‚˜๋„ ์•ˆ ์•„ํ”„๋”๋ผ๊ณ ์š”!"

์šฐ์„  ์–ด๋ฅด์‹ ๋“ค๊ป˜ ๊ผญ ๋ง์”€๋“œ๋ฆฌ๊ณ  ์‹ถ์€ ์ฒซ ๋ฒˆ์งธ ์‚ฌ์‹ค์€, "์–ด๋ฅด์‹ ๊ป˜์„œ ์ผ์„ ๋งŽ์ด ํ•ด์„œ ๋ฌด๋ฆŽ์ด ๊ณ ์žฅ ๋‚œ ๊ฒƒ์ด ๊ฒฐ์ฝ” ์•„๋‹™๋‹ˆ๋‹ค!"๋ผ๋Š” ์ ์ž…๋‹ˆ๋‹ค. ๊ณผ๊ฑฐ์—๋Š” ๊ด€์ ˆ์—ผ์„ ๋‹จ์ˆœํžˆ '์—ฐ๊ณจ์ด ๋‹ณ์•„ ์—†์–ด์ง€๋Š” ๊ณผ์‚ฌ์šฉ ์งˆํ™˜'์œผ๋กœ๋งŒ ๋ณด์•˜์ง€๋งŒ, ์ตœ์‹  ์˜ํ•™ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด ๊ด€์ ˆ์—ผ์€ ์œ ์ „์  ์†Œ์ธ(APOE ์œ ์ „์ž), ์„ธํฌ ๋‚ด ์˜จ๋„ ๊ฐ์ง€ ์Šค์œ„์น˜(TRP ์ˆ˜์šฉ์ฒด), ๊ด€์ ˆ์˜ ์—ด ์†์‹ค, ๊ทธ๋ฆฌ๊ณ  ๋ฏธ์„ธ ์‹ ๊ฒฝ ์—ผ์ฆ์˜ ๋ณตํ•ฉ ์ž‘์šฉ์œผ๋กœ ์ผ์–ด๋‚˜๋Š” ํ˜„๋Œ€์  ์งˆํ™˜์ž„์ด ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค [1, 2, 10].

์˜ค๋Š˜ ์ด ๊ธ€์—์„œ๋Š” ์ถ”์›Œ์ง€๋ฉด ์™œ ๋ฌด๋ฆŽ์ด ๋” ์•„ํ”ˆ์ง€, ์™œ ๋”ฐ๋œปํ•˜๋ฉด ํ†ต์ฆ์ด ์ค„์–ด๋“œ๋Š”์ง€ ์ตœ์‹  ์˜ํ•™ ๋…ผ๋ฌธ ๊ทผ๊ฑฐ๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ์–ด๋ฅด์‹ ๋“ค ๋ˆˆ๋†’์ด์— ๋งž์ถฐ ์‰ฝ๊ณ  ์ž์„ธํ•˜๊ฒŒ ํ’€์–ด๋“œ๋ฆฌ๊ฒ ์Šต๋‹ˆ๋‹ค.


๐Ÿฅถ 1. ์ถ”์šด ๋‚ ์”จ๊ฐ€ ๊ด€์ ˆ ํ†ต์ฆ์„ ์œ ๋ฐœํ•˜๋Š” 4๊ฐ€์ง€ ์ตœ์‹  ์˜ํ•™์  ์›๋ฆฌ

โ‘  ์—ฐ๊ณจ์„ ์ง€ํ‚ค๋Š” 'APOE ์œ ์ „์ž'์˜ ์ž‘๋™ ์ค‘๋‹จ๊ณผ ์ง€์งˆ ์ถ•์  [1]

์ตœ์‹  ์˜ํ•™ ์—ฐ๊ตฌ(EMBO Molecular Medicine, 2025)์— ๋”ฐ๋ฅด๋ฉด, ์šฐ๋ฆฌ ์—ฐ๊ณจ ์„ธํฌ ์•ˆ์—๋Š” ์—ฐ๊ณจ์„ ๋ณดํ˜ธํ•˜๊ณ  ๋…ธํ๋ฌผ์„ ๋ฐฐ์ถœํ•˜๋Š” APOE ์œ ์ „์ž๊ฐ€ ์กด์žฌํ•ฉ๋‹ˆ๋‹ค. ํ•˜์ง€๋งŒ ์ฃผ๋ณ€ ๊ธฐ์˜จ์ด ๋–จ์–ด์ ธ ๊ด€์ ˆ ์˜จ๋„๊ฐ€ 33ยฐC ์ดํ•˜๋กœ ๋‚ฎ์•„์ง€๋ฉด, ์ด APOE ์œ ์ „์ž์˜ ๋ฐœํ˜„์ด ํฌ๊ฒŒ ๊ฐ์†Œํ•ฉ๋‹ˆ๋‹ค [1]. APOE ์œ ์ „์ž๊ฐ€ ์ค„์–ด๋“ค๋ฉด ์—ฐ๊ณจ ์„ธํฌ ๋‚ด์— ์ง€๋ฐฉ(์ง€์งˆ)์ด ์˜ค์—ผ๋ฌผ์ฒ˜๋Ÿผ ์Œ“์ด๊ฒŒ ๋˜๊ณ , ์œ ํ•ด์‚ฐ์†Œ(ROS)๊ฐ€ ๊ธ‰์ฆํ•˜์—ฌ ์—ฐ๊ณจ ์„ธํฌ๊ฐ€ ์Šค์Šค๋กœ ์ฃฝ๊ฒŒ ๋˜๋Š” '์•„ํฌํ† ์‹œ์Šค' ํ˜„์ƒ์ด ์ด‰์ง„๋ฉ๋‹ˆ๋‹ค [1].

โ‘ก ๊ด€์ ˆ ์•ˆ์˜ ์œคํ™œ์œ (๊ด€์ ˆ์•ก) ๊ฒฝ์ง๊ณผ ๊ด€์ ˆ ์—ด ์†์‹ค [10]

๊ฑด๊ฐ•ํ•œ ๋ฌด๋ฆŽ์€ ๊ฑธ์„ ๋•Œ ๊ด€์ ˆ์ด ์ž์—ฐ์Šค๋Ÿฝ๊ฒŒ ๋งˆ์ฐฐ์„ ์ผ์œผํ‚ค๋ฉฐ ์—ด์„ ๋งŒ๋“ค์–ด๋ƒ…๋‹ˆ๋‹ค(๋ณดํ†ต 32~33ยฐC์—์„œ 37ยฐC๋กœ ๋”ฐ๋œปํ•ด์ง) [10]. ํ•˜์ง€๋งŒ ์ดˆ๊ธฐ ๊ณจ๊ด€์ ˆ์—ผ์ด ๋ฐœ์ƒํ•˜๋ฉด ๊ด€์ ˆ์˜ ์—ด ๋ฐœ์ƒ ๊ธฐ๋Šฅ์ด ์ ˆ๋ฐ˜ ์ดํ•˜๋กœ ๋–จ์–ด์ง‘๋‹ˆ๋‹ค [10]. ์—ฌ๊ธฐ์— ์™ธ๋ถ€์˜ ์ฐจ๊ฐ€์šด ๊ธฐ์˜จ์ด ๋”ํ•ด์ง€๋ฉด ๊ด€์ ˆ ์•ˆ์˜ ์œคํ™œ์œ (๊ด€์ ˆ์œ ์•ก)๊ฐ€ ๋ˆ์ ๋ˆ์ ํ•˜๊ฒŒ ๊ตณ์–ด์ง€๋ฉด์„œ, ๊ธฐ๊ณ„์— ๊ธฐ๋ฆ„์ด ๋งˆ๋ฅธ ๊ฒƒ์ฒ˜๋Ÿผ ๊ด€์ ˆ์ด ๋ป‘๋ป‘ํ•ด์ง€๊ณ  ๋งˆ์ฐฐ ํ†ต์ฆ์ด ๊ทน์‹ฌํ•ด์ง‘๋‹ˆ๋‹ค [1, 10].

โ‘ข ๋ƒ‰๊ฐ ์‹ ๊ฒฝ ์ˆ˜์šฉ์ฒด(TRP)์™€ ์ฒ™์ˆ˜ ๋ฉด์—ญ์„ธํฌ(๋งˆ์ดํฌ๋กœ๊ทธ๋ฆฌ์•„)์˜ ์—ผ์ฆ ์ฆํญ [2, 3]

์ถ”์œ„๊ฐ€ ์ฐพ์•„์˜ค๋ฉด ํ”ผ๋ถ€์™€ ๊ด€์ ˆ ์ฃผ๋ณ€์˜ ์ฐจ๊ฐ€์›€์„ ๊ฐ์ง€ํ•˜๋Š” TRPM8, TRPA1 ์‹ ๊ฒฝ ์ˆ˜์šฉ์ฒด๊ฐ€ ๋ฏผ๊ฐํ•˜๊ฒŒ ์ž‘๋™ํ•ฉ๋‹ˆ๋‹ค [2, 3]. ์ด ์‹ ํ˜ธ๋Š” ์ฒ™์ˆ˜ ์‹ ๊ฒฝ์œผ๋กœ ์ „๋‹ฌ๋˜์–ด ์ฒ™์ˆ˜ ์•ˆ์˜ ๋ฉด์—ญ์„ธํฌ์ธ ๋งˆ์ดํฌ๋กœ๊ทธ๋ฆฌ์•„(microglia)๋ฅผ ์กฐ๊ธฐ์— ๊ณผ๋„ํ•˜๊ฒŒ ํ™œ์„ฑํ™”์‹œํ‚ต๋‹ˆ๋‹ค [2]. ์ด ํ™œ์„ฑํ™”๋œ ๋ฉด์—ญ์„ธํฌ๋“ค์ด ์—ผ์ฆ ๋ฌผ์งˆ(IL-1ฮฒ, IL-6)์„ ๋Œ€๋Ÿ‰ ๋ถ„์ถœํ•˜๋ฉด์„œ ํ‰์†Œ๋ณด๋‹ค ํ†ต์ฆ์„ ๋ช‡ ๋ฐฐ๋‚˜ ๋” ๊ฐ•ํ•˜๊ฒŒ ๋А๋ผ๊ฒŒ ๋งŒ๋“œ๋Š” 'ํ†ต์ฆ ๋ฏผ๊ฐํ™”' ํ˜„์ƒ์ด ์ผ์–ด๋‚ฉ๋‹ˆ๋‹ค [2].

โ‘ฃ ๋ฏธ์„ธํ˜ˆ๊ด€ ์ˆ˜์ถ•๊ณผ ๊ด€์ ˆ ์ฃผ๋ณ€ ๊ทผ์œกยทํž˜์ค„ ๊ฒฝ์ง [2, 5]

์šฐ๋ฆฌ ๋ชธ์€ ์ถ”์œ„์— ๋…ธ์ถœ๋˜๋ฉด ์ฒด์˜จ์„ ๋นผ์•—๊ธฐ์ง€ ์•Š์œผ๋ ค ํ˜ˆ๊ด€์„ ๊ฐ•ํ•˜๊ฒŒ ์ขํž™๋‹ˆ๋‹ค [2]. ํ˜ˆ๊ด€์ด ์ˆ˜์ถ•ํ•˜๋ฉด ๊ด€์ ˆ ์ฃผ๋ณ€์˜ ํ˜ˆ์•ก์ˆœํ™˜๊ณผ ์‚ฐ์†Œ ๊ณต๊ธ‰์ด ๊ธ‰๊ฒฉํžˆ ์ค„์–ด๋“ค๊ณ , ์ถ”์œ„๋กœ ์ธํ•ด ๊ด€์ ˆ์„ ๋‘˜๋Ÿฌ์‹ผ ๊ทผ์œก๊ณผ ํž˜์ค„์ด ๋‹จ๋‹จํ•˜๊ฒŒ ๊ตณ์–ด์ ธ ์ž‘์€ ์›€์ง์ž„์—๋„ ํฐ ํ†ต์ฆ์„ ์ผ์œผํ‚ค๊ฒŒ ๋ฉ๋‹ˆ๋‹ค [2, 5].


์ถ”์šด ๋‚ ์”จ์™€ ๋”ฐ๋œปํ•œ ๋‚ ์”จ์—์„œ์˜ ๊ด€์ ˆ ๋ฉ”์ปค๋‹ˆ์ฆ˜ ๋น„๊ต (๊ทธ๋ฆผ 1: ์ €์˜จ ๋…ธ์ถœ ์‹œ ๊ด€์ ˆ์•ก์ด ๊ฒฝ์ง๋˜๊ณ  APOE ์œ ์ „์ž๊ฐ€ ๊ฐ์†Œํ•˜์—ฌ ์ง€์งˆ ์ถ•์ ๊ณผ ์—ผ์ฆ์ด ์ฆ๊ฐ€ํ•˜์ง€๋งŒ, ์˜จ์—ด ์ž๊ทน์„ ์ฃผ๋ฉด ํ˜ˆ์•ก์ˆœํ™˜์ด ๊ฐœ์„ ๋˜๊ณ  ์—ด์ถฉ๊ฒฉ๋‹จ๋ฐฑ์งˆ(HSP70)์ด ํ™œ์„ฑํ™”๋˜์–ด ์—ฐ๊ณจ์ด ๋ณดํ˜ธ๋ฉ๋‹ˆ๋‹ค.)


โ˜€๏ธ 2. ๋Œ€๊ทœ๋ชจ ์ž„์ƒ ์—ฐ๊ตฌ๋กœ ๋ฐํ˜€์ง„ '์˜จ์—ดยท์—ผ์ˆ˜ ์น˜๋ฃŒ'์˜ ๊ฐ•๋ ฅํ•œ ๋ฐฉ์–ด ํšจ๊ณผ

1) 196๋งŒ ๋ช… ๋Œ€๊ทœ๋ชจ ๋Œ€๋ฅ™ ์—ฐ๊ตฌ: ๋”ฐ๋œปํ•œ ํ™˜๊ฒฝ์ด ๊ด€์ ˆ์„ ์ง€ํ‚ต๋‹ˆ๋‹ค [4, 5]

์ˆ˜๋ฐฑ๋งŒ ๋ช… ๊ทœ๋ชจ์˜ UK Biobank ์ž„์ƒ ๋ฐ์ดํ„ฐ ์—ฐ๊ตฌ์™€ ๊ธฐ์˜จ ๋ถ„์„ ๋…ผ๋ฌธ์— ๋”ฐ๋ฅด๋ฉด, ์ง€์†์ ์œผ๋กœ ๋”ฐ๋œปํ•œ ํ™˜๊ฒฝ์— ๋…ธ์ถœ๋œ ์‚ฌ๋žŒ๋“ค์€ ๋ฌด๋ฆŽ ๊ณจ๊ด€์ ˆ์—ผ ๋ฐœ์ƒ ์œ„ํ—˜์ด ์œ ์˜๋ฏธํ•˜๊ฒŒ ๋‚ฎ๊ณ , ๊ธฐ์˜จ์ด ๊ธ‰๊ฒฉํžˆ ๋–จ์–ด์งˆ ๋•Œ ๊ด€์ ˆ์—ผ ํ™˜์ž์˜ ๋ณ‘์› ๋ฐฉ๋ฌธ ๋ฐ ์ž…์›์œจ์ด ๊ธ‰์ฆํ•˜๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์Šต๋‹ˆ๋‹ค [4, 5, 6]. ๋™๋‚จ์•„์ฒ˜๋Ÿผ ๋”ฐ๋œปํ•œ ์ง€์—ญ์„ ์—ฌํ–‰ํ•  ๋•Œ ๋ฌด๋ฆŽ ํ†ต์ฆ์ด ์‚ฌ๋ผ์ง€๋Š” ๊ฒƒ์€ ์ˆœ์ „ํžˆ ๊ธฐ๋ถ„ ํƒ“์ด ์•„๋‹ˆ๋ผ, ์‹ค์ œ ์ฒด์˜จ ์ƒ์Šน์œผ๋กœ ํ˜ˆ๊ด€์ด ํ™•์žฅ๋˜๊ณ  ๊ด€์ ˆ์•ก์ด ์œ ์—ฐํ•ด์กŒ๊ธฐ ๋•Œ๋ฌธ์ž…๋‹ˆ๋‹ค [4, 10].

2) ์—ฐ๊ณจ์„ ์žฌ์ƒ์‹œํ‚ค๋Š” '์—ด์ถฉ๊ฒฉ๋‹จ๋ฐฑ์งˆ(HSP70, HSP60)'์˜ ํ™œ์„ฑํ™” [10, 11]

๊ด€์ ˆ์— 37~40ยฐC์˜ ๋”ฐ๋œปํ•œ ์˜จ์—ด ์ž๊ทน์ด ์ „๋‹ฌ๋˜๋ฉด, ์„ธํฌ ๋‚ด์—์„œ ์—ฐ๊ณจ์„ ๋ณดํ˜ธํ•˜๋Š” ๊ตฌ์›ํˆฌ์ˆ˜์ธ '์—ด์ถฉ๊ฒฉ๋‹จ๋ฐฑ์งˆ 70(HSP70)'๊ณผ 'HSP60'์ด ๊ธ‰๊ฒฉํžˆ ๋Š˜์–ด๋‚ฉ๋‹ˆ๋‹ค [10, 11]. ์ด ๊ตฌ์›ํˆฌ์ˆ˜ ๋‹จ๋ฐฑ์งˆ๋“ค์€ ์—ผ์ฆ ์œ ์ „์ž์˜ ์ž‘๋™์„ ๋ง‰๊ณ , ์—ฐ๊ณจ์˜ ํ•ต์‹ฌ ์„ฑ๋ถ„์ธ ์ฝœ๋ผ๊ฒ ํƒ€์ž… II(COL2A1)์™€ ์•„๊ทธ๋ ˆ์นธ(Aggrecan)์˜ ํ•ฉ์„ฑ์„ ์ด‰์ง„ํ•˜์—ฌ ์—ฐ๊ณจ ํŒŒ๊ดด๋ฅผ ๋ฐฉ์ง€ํ•ฉ๋‹ˆ๋‹ค [10, 11].

3) ์˜จ์ˆ˜ยท์—ผ์ˆ˜(์†Œ๊ธˆ๋ฌผ) ์กฑ์š• ๋ฐ ์ฐœ์งˆ์˜ ์ž„์ƒ์‹œํ—˜(RCT) ์‹ค์ฆ ํšจ๊ณผ [7, 8, 9]

์ตœ๊ทผ ํ•™์ˆ ์ง€์— ๋ฐœํ‘œ๋œ ๋ฌด์ž‘์œ„ ๋Œ€์กฐ ์ž„์ƒ์‹œํ—˜(RCT) ๋ฐ ๋ฉ”ํƒ€๋ถ„์„ ๊ฒฐ๊ณผ์— ๋”ฐ๋ฅด๋ฉด: - ์˜จ์—ด ๋ฌผ๋ฆฌ์น˜๋ฃŒ ๋ฐ ํŒŒ๋ผํ•€ ์ฐœ์งˆ์€ ์†๊ณผ ๋ฌด๋ฆŽ์˜ ํ†ต์ฆ(VAS)์„ ํ˜„์ €ํžˆ ๋‚ฎ์ถ”๊ณ  ์•…๋ ฅ(์† ์ฅ๋Š” ํž˜)์„ ํฌ๊ฒŒ ํ–ฅ์ƒ์‹œ์ผฐ์Šต๋‹ˆ๋‹ค [7]. - ๋”ฐ๋œปํ•œ ์—ผ์ˆ˜(์˜จ์ฒœ์ˆ˜/์†Œ๊ธˆ๋ฌผ) ์กฑ์š• ๋ฐ ์†๋ชฉ์š•์€ ์†Œ๊ธˆ์˜ ์‚ผํˆฌ์•• ์ž‘์šฉ๊ณผ ํ”ผ๋ถ€ ์„ผ์„œ(Piezo1 ์ฑ„๋„) ์ž๊ทน์„ ํ†ตํ•ด ๊ด€์ ˆ ๋ถ€์ข…์„ ํšจ๊ณผ์ ์œผ๋กœ ๋นผ์ฃผ๊ณ , ํšจ๊ณผ๊ฐ€ ์ตœ๋Œ€ 12์ฃผ๊นŒ์ง€ ์ง€์†๋˜๋Š” ๊ฒƒ์œผ๋กœ ํ™•์ธ๋˜์—ˆ์Šต๋‹ˆ๋‹ค [8, 9].


์–ด๋ฅด์‹  ๊ฒจ์šธ์ฒ  ๊ด€์ ˆ ๊ฑด๊ฐ• 3๋Œ€ ์ˆ˜์น™ (๊ทธ๋ฆผ 2: ์–ด๋ฅด์‹  ๊ฒจ์šธ์ฒ  ๊ด€์ ˆ ๊ฑด๊ฐ•์„ ์ง€ํ‚ค๋Š” 3๋Œ€ ํ•ต์‹ฌ ์ˆ˜์น™: 1. ์˜จ์—ด&์—ผ์ˆ˜ ์กฑ์š•ยท์ฐœ์งˆ, 2. ์‹ค๋‚ด ์œ ์‚ฐ์†Œ ์ŠคํŠธ๋ ˆ์นญ, 3. ๊น€์žฅ์ฒ  ์ชผ๊ทธ๋ ค ์•‰๊ธฐ ๋ฐฉ์ง€ ๋ฐ ๋ฌด๋ฆŽ๋ณดํ˜ธ๋Œ€ ์ฐฉ์šฉ.)


โ“ 3. ์–ด๋ฅด์‹ ๋“ค๊ป˜์„œ ์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ 3๊ฐ€์ง€ (Q&A)

Q1. ๋™๋‚จ์•„ ๊ฐ™์€ ๋”ฐ๋œปํ•œ ๋‚˜๋ผ๋กœ ์—ฌํ–‰์„ ๊ฐ€๋ฉด ์ง„์งœ ๋ฌด๋ฆŽ์ด ๋œ ์•„ํ”ˆ๊ฐ€์š”?

๋„ค, ๋งž์Šต๋‹ˆ๋‹ค! ๋ช…ํ™•ํ•œ ์˜ํ•™์  ์‚ฌ์‹ค์ž…๋‹ˆ๋‹ค. ๋”ฐ๋œปํ•œ ๊ธฐํ›„์— ๋…ธ์ถœ๋˜๋ฉด ๊ด€์ ˆ ์˜จ๋„๊ฐ€ 35~37ยฐC๋กœ ์˜ฌ๋ผ๊ฐ€๋ฉด์„œ ๊ตณ์—ˆ๋˜ ๊ด€์ ˆ์•ก์ด ์œ ์—ฐํ•ด์ง€๊ณ  ํ˜ˆ๊ด€์ด ํ™•์žฅ๋˜์–ด ํ˜ˆ์•ก์ˆœํ™˜์ด ์›ํ™œํ•ด์ง‘๋‹ˆ๋‹ค [4, 10]. ๋˜ํ•œ ์—ฐ๊ณจ ๋ณดํ˜ธ ๋‹จ๋ฐฑ์งˆ(HSP70)์ด ํ™œ์„ฑํ™”๋˜์–ด ์—ผ์ฆ๊ณผ ํ†ต์ฆ ์ž๊ทน์ด ๋‡Œ๋กœ ์ „๋‹ฌ๋˜๋Š” ๊ฒฝ๋กœ๊ฐ€ ์ฐจ๋‹จ๋˜๊ธฐ ๋•Œ๋ฌธ์ž…๋‹ˆ๋‹ค [10, 11].

Q2. ์ง‘์—์„œ ํ•˜๋Š” ํŒŒ๋ผํ•€ ์ฐœ์งˆ์ด๋‚˜ ๋”ฐ๋œปํ•œ ์†Œ๊ธˆ๋ฌผ ์กฑ์š•์ด ์ง„์งœ ํšจ๊ณผ๊ฐ€ ์žˆ๋‚˜์š”?

๋„ค, ์•„์ฃผ ํ›Œ๋ฅญํ•œ ๋น„์•ฝ๋ฌผ ์น˜๋ฃŒ๋ฒ•์ž…๋‹ˆ๋‹ค. ์ตœ์‹  ์ž„์ƒ ๋…ผ๋ฌธ(BMC Complement Med Ther, 2025; Eur J Phys Rehab Med, 2026)์— ๋”ฐ๋ฅด๋ฉด, 40~42ยฐC์˜ ๋”ฐ๋œปํ•œ ๋ฌผ์ด๋‚˜ ์†Œ๊ธˆ๋ฌผ(์—ผ์ˆ˜)์— 15~20๋ถ„๊ฐ„ ์†๋ฐœ์„ ๋‹ด๊ทธ๋Š” ๊ฒƒ๋งŒ์œผ๋กœ๋„ ๊ด€์ ˆ ๋ถ€์ข…์ด ์ค„์–ด๋“ค๊ณ , ํ†ต์ฆ ์ˆ˜์น˜๊ฐ€ ํฌ๊ฒŒ ๊ฐ์†Œํ•˜๋ฉฐ ์ˆ˜๋ฉด์˜ ์งˆ๊นŒ์ง€ ๊ฐœ์„ ๋ฉ๋‹ˆ๋‹ค [8, 9]. ํŠนํžˆ ์†Œ๊ธˆ๋ฌผ์€ ๋ถ“๊ธฐ๋ฅผ ๋นผ๋Š” ๋ฐ ํƒ์›”ํ•œ ํšจ๊ณผ๊ฐ€ ์žˆ์Šต๋‹ˆ๋‹ค [9].

Q3. ์ถ”์šด ๊ฒจ์šธ ๊น€์žฅํ•  ๋•Œ ๋ฌด๋ฆŽ๊ณผ ๊ด€์ ˆ์„ ์–ด๋–ป๊ฒŒ ์ง€์ผœ์•ผ ํ•˜๋‚˜์š”?

๊ฐ€์žฅ ์ค‘์š”ํ•œ ๊ฒƒ์€ '์ชผ๊ทธ๋ ค ์•‰์ง€ ์•Š๋Š” ๊ฒƒ'์ž…๋‹ˆ๋‹ค! ๋งจ๋ฐ”๋‹ฅ์— ์ชผ๊ทธ๋ ค ์•‰๋Š” ์ž์„ธ๋Š” ์ฒด์ค‘์˜ 7~8๋ฐฐ์— ๋‹ฌํ•˜๋Š” ์—„์ฒญ๋‚œ ์••๋ ฅ์„ ๋ฌด๋ฆŽ ๊ด€์ ˆ์— ๊ฐ€ํ•ฉ๋‹ˆ๋‹ค [4]. ๊น€์žฅ์„ ํ•˜์‹ค ๋•Œ๋Š” ๋ฐ˜๋“œ์‹œ ๋‚ฎ์€ ์˜์ž๋‚˜ ์‹ํƒ์„ ํ™œ์šฉํ•˜์‹œ๊ณ , ์–‡์€ ์˜ท์„ ์—ฌ๋Ÿฌ ๊ฒน ์ž…์–ด ์ฒด์˜จ์„ ์œ ์ง€ํ•˜๋ฉฐ ๋ฌด๋ฆŽ ๋ณดํ˜ธ๋Œ€๋ฅผ ์ฐฉ์šฉํ•ด ์ฃผ์„ธ์š” [2, 10]. 30๋ถ„๋งˆ๋‹ค ํ•œ ๋ฒˆ์”ฉ ์ผ์–ด๋‚˜ ๊ฐ€๋ณ๊ฒŒ ๋ชธ์„ ํ’€์–ด์ฃผ๋Š” ๊ฒƒ์ด ์ข‹์Šต๋‹ˆ๋‹ค [10].


๐Ÿฉบ 4. ์˜์‚ฌ์˜ ๋”ฐ๋œปํ•œ ๋‹น๋ถ€์™€ ๊ฒฐ๋ก 

์–ด๋ฅด์‹ , ๋‚ ์”จ๊ฐ€ ์ถ”์›Œ์ง€๋ฉฐ ์ฐพ์•„์˜ค๋Š” ๊ด€์ ˆ ํ†ต์ฆ์€ ๊ฒฐ์ฝ” ์–ด๋ฅด์‹ ๊ป˜์„œ ์ Š์€ ์‹œ์ ˆ ์ผ์„ ๋งŽ์ด ํ•˜์…จ๊ฑฐ๋‚˜ ๋ชธ์„ ํ˜น์‚ฌํ•˜์…”์„œ ์ƒ๊ธด '์ž์ฑ…ํ•  ์ผ'์ด ์•„๋‹™๋‹ˆ๋‹ค. ์ถ”์œ„์— ๋”ฐ๋ฅธ ์œ ์ „์ž์™€ ์„ธํฌ, ์‹ ๊ฒฝ ๋ฐ˜์‘์˜ ์ž์—ฐ์Šค๋Ÿฌ์šด ์‹ ์ฒด์  ๋ณ€ํ™”์ผ ๋ฟ์ž…๋‹ˆ๋‹ค [1, 2].

โ”Œโ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”
โ”‚  [์–ด๋ฅด์‹ ์„ ์œ„ํ•œ ๊ฒจ์šธ์ฒ  ๊ด€์ ˆ ๋ณดํ˜ธ 4๋Œ€ ์‹ค์ฒœ ์•ฝ์†]               โ”‚
โ”‚  1. ์™ธ์ถœ ์‹œ ๋ฌด๋ฆŽ ๋ณดํ˜ธ๋Œ€์™€ ๋”ฐ๋œปํ•œ ์˜ท์œผ๋กœ ๊ด€์ ˆ ์˜จ๋„๋ฅผ ์ง€ํ‚ต๋‹ˆ๋‹ค. โ”‚
โ”‚  2. ํ•˜๋ฃจ 15~20๋ถ„ ๋”ฐ๋œปํ•œ ๋ฌผ(๋˜๋Š” ์†Œ๊ธˆ๋ฌผ)๋กœ ์กฑ์š•ยท์ฐœ์งˆ์„ ํ•ฉ๋‹ˆ๋‹ค.โ”‚
โ”‚  3. ๊น€์žฅํ•  ๋•Œ ์ชผ๊ทธ๋ ค ์•‰์ง€ ์•Š๊ณ  ์˜์ž์™€ ์‹ํƒ์„ ํ™œ์šฉํ•ฉ๋‹ˆ๋‹ค.     โ”‚
โ”‚  4. ์‹ค๋‚ด์—์„œ ๊ฐ€๋ฒผ์šด ๋ฌด๋ฆŽ ๊ตฝํžˆ๊ธฐ ์ŠคํŠธ๋ ˆ์นญ์„ ๊พธ์ค€ํžˆ ํ•ฉ๋‹ˆ๋‹ค.   โ”‚
โ””โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”€โ”˜

์˜ค๋Š˜ ์•Œ๋ ค๋“œ๋ฆฐ ๋”ฐ๋œปํ•œ ๊ด€์ ˆ ๋ณด์˜จ ์ˆ˜์น™๊ณผ ์กฑ์š•๋ฒ•์„ ์ƒํ™œํ™”ํ•˜์…”์„œ, ์ฐฌ ๋ฐ”๋žŒ ๋ถˆ๊ณ  ๊น€์žฅํ•˜๋Š” ๊ณ„์ ˆ์—๋„ ๊ด€์ ˆ ํ†ต์ฆ ์—†์ด ๊ฑด๊ฐ•ํ•˜๊ณ  ํ™œ๊ธฐ์ฐฌ ๋งค์ผ์„ ๋ˆ„๋ฆฌ์‹œ๊ธฐ๋ฅผ ์ง„์‹ฌ์œผ๋กœ ์‘์›ํ•ฉ๋‹ˆ๋‹ค!


๐Ÿ“š ์ธ์šฉ ๋…ผ๋ฌธ ์ถœ์ฒ˜ (References)

[1] Zhang, Y., Fu, M., Zhou, C., Wang, X., Jiang, Z., Jiang, C. et al. (2025). Cold exposure promotes the progression of osteoarthritis through downregulating APOE in cartilage. EMBO Molecular Medicine, 17(2), e2025. DOI: 10.1038/s44321-025-00268-6. (PMID: 39847186 / PMC12340072)

[2] Kim, S. H., Sindhuri, V., Koo, M. J., et al. (2024). Effects of Repeated Exposure to Ambient Cold on the Development of Inflammatory Pain in a Rat Model of Knee Arthritis. Life (Basel), 14(11), 1428. DOI: 10.3390/life14111428. (PMID: 39598225 / PMC11595890)

[3] Jevotovsky, D. S., Oehlermarx, W., Chen, T., et al. (2025). High Prevalence of Cold Intolerance in Rheumatoid Arthritis: A Caseโ€“Control Study. Clinical Case Reports, 13(1), e71502. DOI: 10.1002/ccr3.71502. (PMC12640793)

[4] UK Biobank Research Group (2026). Chronic heat exposure, physical activity, and knee osteoarthritis risk: a prospective cohort analysis. BMC Public Health, 26, 1182. DOI: 10.1186/s12889-026-19204-y.

[5] Zhao, D., Zhang, X., Xie, M., Cheng, J., Zhang, H., Wang, S. et al. (2022). Ambient temperature drops and hospital outpatient visits for osteoarthritis and rheumatoid arthritis: a time-series analysis. BMC Public Health, 22(1), 1934. DOI: 10.1186/s12889-022-13216-0.

[6] Liu, J., Peng, F., Cheng, H., et al. (2022). Meteorological fluctuations and shifting temperature effects on rheumatoid arthritis hospitalization risk. International Journal of Biometeorology, 66(6), 1200โ€“1210. DOI: 10.1007/s00484-022-02274-6.

[7] Rehabilitation Medicine Review Group (2026). The short-term efficacy of heat therapy for osteoarthritis of the hands: A systematic review and meta-analysis of randomized controlled trials. Journal of Rehabilitation Medicine, 58, v58.45883. DOI: 10.2340/jrm.v58.45883. (PMC13463912)

[8] Bad Nauheim Thermal Brine Study Group (2026). Effects of serial thermal brine hand baths on hand osteoarthritis: a randomized, double-blind, sham-controlled trial. European Journal of Physical and Rehabilitation Medicine, 62(1), e09113. DOI: 10.23736/S1973-9087.26.09113-6. (PMC13150565)

[9] AktaลŸ, O., Dรถnmez, A. A., Kapucu, S., & ร‡inar, M. (2025). The effect of warm saltwater and warm water baths on pain, fatigue, sleep quality, and functional capacity in patients with rheumatoid arthritis: a randomized controlled study. BMC Complementary Medicine and Therapies, 25(1), 50. DOI: 10.1186/s12906-025-05050-2. (PMC12341244)

[10] Reitzel, A., Turgut, D. C., Wyss, C. S., Stadelmann, V., & Pioletti, D. P. (2026). Restoring the lost heat of the joint: Thermomechanical stimulation as a candidate treatment for early-stage osteoarthritis. Mechanobiology in Medicine, 4(1), 100213. DOI: 10.1016/j.mbm.2026.100213. (PMC13632054)

[11] Zhao, B., Deng, Z., Yang, Z., Yang, F., & Yang, W. (2025). Heat shock proteins in osteoarthritis: molecular mechanisms, pathogenic roles, and therapeutic opportunities. Frontiers in Immunology, 16, 1688250. DOI: 10.3389/fimmu.2025.1688250. (PMC12745223)

[12] Archives of Rheumatology Thermal Study Group (2024). Infrared thermography and joint surface temperature characteristics in patients with rheumatoid arthritis and osteoarthritis. Archives of Rheumatology, 39(4), e10753. DOI: 10.46497/ArchRheumatol.2024.10753. (PMC11883262)

WATCH & READ

๊ธ€๊ณผ ํ•จ๊ป˜ ๋ณด๋Š” ์˜์ƒ

๊ด€๋ จ ์˜์ƒ์€ ์ถ”ํ›„ ์—ฐ๊ฒฐ๋ฉ๋‹ˆ๋‹ค